fbpx Skip to main content

Members in Action

Biocom is proud of the swift actions of our member companies and the work they are doing to address COVID-19. Check this page for the latest information, guidance and updates from Biocom and our partners regarding the novel coronavirus (COVID-19) as it relates to California’s life science industry.

Abbvie

Abbvie

  • Doctors in China have started using a combination of AbbVie Inc.’s HIV drugs ritonavir and lopinavir at hospitals. A clinical trial is assessing whether the combination, sold under the brand name Kaletra, is more effective than an antiviral medicine known as interferon-alpha 2b in treating patients – Read More – Bloomberg
AccendoWave

AccendoWave

  • COVID-19 Infection Control Solution for Hospitals; Providing Hospital Grade Cell Phone UV Sanitizing and Charging Carts to Hospital ED’s, L&D, and ICU’s. Hospital grade UV cell sanitizing for 72 cell phones in an hour – Learn More
  • Infection Control: Linking Corporations with Hospitals – Read More
Amgen

Amgen

  • Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts – Read More
Aragen

Aragen

  • Aragen is producing reagents that are incorporated into COVID-19 test kits.
Argonaut

Argonaut

  • Argonaut has immediate aseptic fill/finish capacity for COVID-19 vaccines and therapies – Learn More
Augmenta Bioworks

Augmenta Bioworks

  • Working on treatments for COVID-19.
Avomeen

Avomeen

Chan Zuckerberg

Chan Zuckerberg

COVID-19 Response Task Force

COVID-19 Response Task Force

  • Los Angeles members including Lab Launch, Caltech, Karma Biotechnologies, as well partners at MarsBio and more, have created a taskforce to combat COVID-19
  • They are doing this by seeking proposals for ideas on the following: Public safety and prevention, Operational response, Vaccine development, Treatment mechanisms, and Point of care diagnostics – Learn More
  • LA County’s First Bioscience Fund Could Fuel COVID-19 Testing and Vaccine – Read More

Distributed Bio

Distributed Bio

  • Coronavirus spreads faster than influenza, scientist from Netflix’s ‘Pandemic’ says – Read More – Fox
Drug Delivery Experts

Drug Delivery Experts

  • Maintaining laboratory operations for some critical pharmaceutical drug development programs for client projects.
  • Donating PPE for clinical use (gloves, masks, gowns).
  • Continuing the work to complete a sterile fill finish suite (available July 2020) so that we can serve as one of the 4 or 5 GMP suites for injectable clinical supplies and GLP preclinical supplies in the San Diego area.
eClinical Solutions

eClinical Solutions

  • To help support and monitor the risk and impact of Covid-19 on your trials, eCS is developing a set of standard elluminate analytics to aid in these efforts. These include helping clients track and forecast missed visits to identify those sites and patients that may need greater support and Covid-19 patient exposure analytics – Learn More
Gilead

Gilead

  • Assisting in development and testing of therapies (trial).
  • Working with Chinese health authorities to set up a randomized clinical trial in the country of its experimental antiviral drug remdesivir (used for Ebola), which has shown some potential in animal studies against the related coronaviruses MERS and SARS.
  • Bring deep experience in antiviral research and development and the global reach that many of the dozen or so biotechs working on coronavirus therapeutics lack. Has drawn attention for the potential of its antiviral drug remdesivir (now are accelerating lab testing of this drug to see its affects against coronavirus).
  • Read More – BioPharma Dive
  • Read More – The Economist
GSK

GSK

  • Assisting in development and testing of therapies.
  • One of the world’s largest producers of vaccines, has made its vaccine adjuvant technology (makes vaccines more effective & boosts immunity) available to companies and universities partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) on coronavirus vaccine development.
  • Brings deep experience in antiviral research and development and the global reach that many of the dozen or so biotechs working on coronavirus therapeutics lack.
  • In theory, the adjuvant should cut the amount of antigen that is needed to create effective vaccines. That benefit, known as antigen sparing, is particularly sought after during pandemic outbreaks as it enables more people to be vaccinated using available antigen supplies.
  • Coalition for Epidemic Preparedness Innovations (backed by Bill & Melinda Gates Foundation).
  • Australia’s University of Queensland is the first CEPI-partnered group to formalize an agreement with GSK, which will supply its AS03 adjuvant system to the university. – Read More – Fierce Biotech
Illumina

Illumina

  • IDbyDNA and Illumina have partnered to bring next-generation sequencing (NGS) workflows to the global microbiology market to combat the COVID-19 pandemic – Read More
IndieBio

IndieBio

Inovio Pharmaceuticals

Inovio Pharmaceuticals

  • The Coalition for Epidemic Preparedness Innovations signed contracts with drugmakers including Moderna and Inovio Pharmaceuticals Inc. as early as Jan. 22 to expedite work. – Read More – Bloomberg
Johnson & Johnson

Johnson & Johnson

  • Working on production of a COVID-19 vaccine. Received $450 Million Coronavirus vaccine contribution with U.S. government – Read More
La Jolla Institute for Immunology

La Jolla Institute for Immunology

  • In search of antibodies that can treat COVID-19, a strategy that public health officials say could end up saving countless lives as the pandemic unfolds – Read More
Ligand Pharmaceuticals

Ligand Pharmaceuticals

  • Using technology to boost drug solubility as part of Gilead’s antiviral drug remdesivir that’s undergoing testing for COVID-19 – Read More
Lucidant

Lucidant

  • Lucidant Polymers is a specialty polymers manufacturer which directly supplying materials for RNA and DNA sequencing.  Data derived from that is key to understanding the spread of coronavirus, its mutation rates and should provide vital clues on the efficiency of any potential vaccine.
Mammoth Biosciences

Mammoth Biosciences

  • Given the global health emergency, rapid transmission, and severe respiratory disease associated with the outbreak of the 2019 novel coronavirus (SARS-CoV-2), Mammoth Biosciences has reconfigured our ​DETECTR platform to rapidly and accurately detect SARS-CoV-2 using a visual lateral flow strip format within 30 minutes from sample to result – Read More – Mammoth Biosciences
Scanwell Health

Scanwell Health

  • An At-Home Coronavirus Test May Be on the Way in the U.S. – Read More
Sorrento Therapeutics and Celularity

Sorrento Therapeutics and Celularity

  • Both companies have initiated a clinical and manufacturing collaboration to expand therapeutic use of existing cell therapy.
  • Companies have a longstanding relationship and both have expressed interest in starting clinical development efforts for anti-coronavirus allogeneic NK cell therapy immediately.
  • Looking to expand use of Celularity’s CYNK-001, an allogeneic, off-the-shelf, placental-derived Natural Killer (NK) cell therapy, to the treatment and prevention of coronavirus infections.
  • Sorrento would utilize current existing capacity in its “state-of-the-art” cGMP cell therapy manufacturing facilities in San Diego to supplement Celularity’s new cGMP facility in Florham Park, New Jersey. The combined capacity would support the rapid scale-up and sustained production of the novel cell therapy.
  • Sorrento in contact with leading scientists and local Chinese experts to discuss clinical validation and logistics requirements to fast-track CYNK-001 cell therapy available in China for this particularly urgent indication.
  • Read More – BioSpace
ThermoFisher Scientific

ThermoFisher Scientific

  • Providing genetic analysis solutions for coronavirus 2019-nCoV.
  • Thermo Fisher Scientific is an industry-leading, worldwide, trusted partner with comprehensive, end-to-end solutions for pathogen detection; scientific expertise; and the support capabilities critical to combating the current outbreak.
  • Utilizes Applied Biosystems TaqMan Assay technology to provide specific, sensitive, and accurate results.
  • Read More – ThermoFisher
  • Thermo Fisher to produce millions of coronavirus diagnostic tests
TRACER

TRACER

  • The 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗥𝗔𝗣𝗜𝗗 𝗖𝗨𝗥𝗘 𝗧𝗔𝗦𝗞 𝗙𝗢𝗥𝗖𝗘, a collaboration between TRACER and the University Medical Center Groningen, is offering the global community unique access to immediately generate in-human data on a potential COVID-19 treatment or vaccine by providing expertise, infrastructure and capacity
  • Read their announcement here and learn more about the task force here
TriLink

TriLink

  • In operation in order to supply mission-critical products to customers, who are in turn developing life-saving medications and diagnostic tests – Read More
UCSD

UCSD

  • Evaluating a new diagnostic testing system designed by Fluxergy that could dramatically reduce wait times for COVID-19 testing in patients – Read More
  • UC San Diego engineers and doctors team up to retrofit and 3-D print ventilators – Read More
Vir Biotechnology

Vir Biotechnology

  • Vir Biotechnology Announces Research Collaboration with the National Institutes of Health Vaccine Research Center on Antibodies Against Coronaviruses
  • Read More
Xencor

Xencor

  • Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend™ XmAb® Antibody Technology in Investigational Antibodies to Treat COVID-19 – Read More

See Also:

Biocom takes a global approach in all that we do. As a representative of over 1,300 organizations connected to California’s life science industry, we strive to provide information that could benefit this community and their pursuit of innovation. The above resources are not to be taken as medical advice but as a means to stay informed and updated.